Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christian Werno
Observed names:
C. Werno,
Werno, Christian
Institution:
Fraunhofer Institute for Toxicology and Experimental Medicine
Observed institutions:
Goethe University Frankfurt,
Fraunhofer Institute for Toxicology and Experimental Medicine,
German Center for Lung Research
ORCID:
0009-0001-1647-4804
Observed ORCID:
0009-0001-1647-4804
OpenAlex ID:
A5031810671
Early dissemination seeds metastasis in breast cancer
2016
·
Hedayatollah Hosseini
, Milan M. S. Obradović
, et al.
·
Nature
·
805
Knockout of HIF-1 in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses
2010
·
C. Werno
, H. Menrad
, et al.
·
Carcinogenesis
·
180
Roles of Hypoxia-Inducible Factor-1α (Hif-1α) Versus Hif-2α in the Survival of Hepatocellular Tumor Spheroids
2010
·
Heidi Menrad
, Christian Werno
, et al.
·
Hepatology
·
145
PDF
Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti‐inflammatory phenotype
2009
·
Andreas Weigert
, Susanne Schiffmann
, et al.
·
International Journal of Cancer
·
113
PDF
Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma
2018
·
Melanie Werner-Klein
, Sebastian Scheitler
, et al.
·
Nature Communications
·
101
PDF
Single-cell microRNA sequencing method comparison and application to cell lines and circulating lung tumor cells
2021
·
Sarah M. Hücker
, Tobias Fehlmann
, et al.
·
Nature Communications
·
93
PDF
Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency
2020
·
Melanie Werner-Klein
, Ana Grujovic
, et al.
·
Nature Communications
·
62
PDF
The supernatant of apoptotic cells causes transcriptional activation of hypoxia-inducible factor–1α in macrophages via sphingosine-1-phosphate and transforming growth factor-β
2009
·
Barbara Herr
, Jie Zhou
, et al.
·
Blood
·
52
PDF
A23187, ionomycin and thapsigargin upregulate mRNA of HIF‐1α via endoplasmic reticulum stress rather than a rise in intracellular calcium
2007
·
Christian Werno
, Jie Zhou
, et al.
·
Journal of Cellular Physiology
·
50
Immune Humanization of Immunodeficient Mice Using Diagnostic Bone Marrow Aspirates from Carcinoma Patients
2014
·
Melanie Werner-Klein
, Judith Proske
, et al.
·
PLoS ONE
·
28
PDF
MCSP+ metastasis founder cells activate immunosuppression early in human melanoma metastatic colonization
2025
·
Severin Guetter
, Courtney König
, et al.
·
Nature Cancer
·
23
A Combination of Hypoxia and Lipopolysaccharide Activates Tristetraprolin to Destabilize Proinflammatory mRNAs such as Tumor Necrosis Factor-α
2010
·
Christian Werno
, Tobias Schmid
, et al.
·
American Journal Of Pathology
·
19
PDF
Ex vivo expansion of lung cancer‐derived disseminated cancer cells from lymph nodes identifies cells associated with metastatic progression
2023
·
Steffi Treitschke
, Kathrin Weidele
, et al.
·
International Journal of Cancer
·
7
PDF
Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patients
2024
·
Nataša Stojanović Gužvić
, Florian Lüke
, et al.
·
Molecular Oncology
·
5
TheraVision: Engineering platform technology for the development of oncolytic viruses based on herpes simplex virus type 1
2024
·
Christina Funk
, Nadja Uhlig
, et al.
·
Molecular Therapy Oncology
·
5
Predicting therapy response by analysis of metastasis founder cells: emerging perspectives for personalized tumor therapy
2020
·
Christian Werno
, Kamran Honarnejad
, et al.
·
Expert Review of Precision Medicine and Drug Development
·
2
Micrometastasis-derived models enable drug testing for early-stage, high-risk melanoma patients
2025
·
Kathrin Weidele
, Christian Werno
, et al.
·
EMBO Molecular Medicine
·
1
PDF
267eP Detection and sorting of rare circulating tumor cells in whole blood of prostate cancer patients by flow cytometry for molecular profiling
2025
·
B. Polzer
, K. Weidele
, et al.
·
Annals of Oncology
·
1
Unraveling the diagnostic potential of disseminated and circulating cancer cells: a case study of a 34-years-old patient with rapidly progressing breast cancer
2024
·
J. Roth
, L. Wöhrl
, et al.
·
Geburtshilfe und Frauenheilkunde
·
1
Lysosomal acid lipase-activity as a novel target to efficiently address triple-negative breast cancer high malignancy
2023
·
H. Steigerwald
, T. Bozzetti
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Abstract LB-312: Interleukin 6 transsignaling is a candidate mechanism to drive progression of human DCCs during periods of clinical latency
2019
·
Melanie Werner-Klein
, Ana Grujovic
, et al.
·
Cancer Research
·
1
Plattform für Ex Vivo Drug Response Assays für die personalisierte funktionelle Testung von Krebsmedikamenten in Patient/innenproben (PEDRA)
2026
·
Wöhrl, Lukas
, Werno, Christian
, et al.
·
RENATE
Ex vivo drug testing in metastatic biopsies reveals patient-specific vulnerabilities to cancer targeting and immune activating drugs
2026
·
Lukas Wöhrl
, Durdam Das
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Micrometastasis-derived models enable drug testing for early-stage, high-risk melanoma patients
2026
·
Weidele, Kathrin
, Werno, Christian
, et al.
·
Fraunhofer-Publica (Fraunhofer-Gesellschaft)
Abstract P2-04-15: Diagnostic potential of disseminated and circulating cancer cells: A case study of a 34-years-old patient with rapidly progressing breast cancer
2025
·
Jonas Roth
, Clara Chaiban
, et al.
·
Clinical Cancer Research
Show more works
View as search
Works count:
39
Citation count:
1,695
H-index:
12
I10-index:
12
Year
Topic
Type